Eli Lilly (Spain)

526 papers and 14.7k indexed citations i.

About

In recent decades, authors affiliated with Eli Lilly (Spain) have published 526 papers, which have received a total of 14.7k indexed citations. Scholars at this organization have produced 118 papers in Molecular Biology, 85 papers in Psychiatry and Mental health and 82 papers in Oncology on the topics of Diabetes Treatment and Management (61 papers), Health Systems, Economic Evaluations, Quality of Life (46 papers) and Advanced Breast Cancer Therapies (43 papers). Their work is cited by papers focused on Oncology (3.2k citations), Molecular Biology (3.0k citations) and Pulmonary and Respiratory Medicine (2.6k citations). Authors at Eli Lilly (Spain) collaborate with scholars in Spain, United States and United Kingdom and have published in prestigious journals including The Lancet, Journal of the American Chemical Society and Angewandte Chemie International Edition. Some of Eli Lilly (Spain)'s most productive authors include José Antonio Sacristán, Tatiana Dilla, Inmaculada Gilaberte, Luis Prieto, Alfonso de Dios, Marı́a José Lallena, Concepción Sánchez‐Martínez, Enric Álvarez, Antonio Ciudad and Ángel Rodríguez.

In The Last Decade

Fields of papers published by authors at Eli Lilly (Spain)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Eli Lilly (Spain) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Eli Lilly (Spain) at the time of their publication.

Countries citing scholars working at Eli Lilly (Spain)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Eli Lilly (Spain). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Eli Lilly (Spain) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Lilly (Spain) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025